Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 213

1.

Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival.

Sarmiento JM, Heywood G, Rubin J, Ilstrup DM, Nagorney DM, Que FG.

J Am Coll Surg. 2003 Jul;197(1):29-37.

PMID:
12831921
2.

Hepatic surgery for metastases from neuroendocrine tumors.

Sarmiento JM, Que FG.

Surg Oncol Clin N Am. 2003 Jan;12(1):231-42. Review.

PMID:
12735141
3.

Hepatic neuroendocrine metastases: does intervention alter outcomes?

Chamberlain RS, Canes D, Brown KT, Saltz L, Jarnagin W, Fong Y, Blumgart LH.

J Am Coll Surg. 2000 Apr;190(4):432-45.

PMID:
10757381
4.

Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.

Norton JA, Kivlen M, Li M, Schneider D, Chuter T, Jensen RT.

Arch Surg. 2003 Aug;138(8):859-66.

PMID:
12912744
5.

Hepatic resection for metastatic neuroendocrine carcinomas.

Que FG, Nagorney DM, Batts KP, Linz LJ, Kvols LK.

Am J Surg. 1995 Jan;169(1):36-42; discussion 42-3.

PMID:
7817996
6.

Cryoablation and liver resection for noncolorectal liver metastases.

Goering JD, Mahvi DM, Niederhuber JE, Chicks D, Rikkers LF.

Am J Surg. 2002 Apr;183(4):384-9.

PMID:
11975925
7.

Isolated liver metastases from neuroendocrine tumors: does resection prolong survival?

Chen H, Hardacre JM, Uzar A, Cameron JL, Choti MA.

J Am Coll Surg. 1998 Jul;187(1):88-92; discussion 92-3.

PMID:
9660030
8.

Hepatic metastases of gastroenteropancreatic neuroendocrine tumors: safe hepatic surgery.

Jaeck D, Oussoultzoglou E, Bachellier P, Lemarque P, Weber JC, Nakano H, Wolf P.

World J Surg. 2001 Jun;25(6):689-92.

PMID:
11376398
9.

Metastatic neuroendocrine hepatic tumors: resection improves survival.

Musunuru S, Chen H, Rajpal S, Stephani N, McDermott JC, Holen K, Rikkers LF, Weber SM.

Arch Surg. 2006 Oct;141(10):1000-4; discussion 1005.

PMID:
17043278
10.

Rationale for the combination of cryoablation with surgical resection of hepatic tumors.

Cha C, Lee FT Jr, Rikkers LF, Niederhuber JE, Nguyen BT, Mahvi DM.

J Gastrointest Surg. 2001 Mar-Apr;5(2):206-13.

PMID:
11331484
11.

Chromogranin A, a marker of the therapeutic success of resection of neuroendocrine liver metastases: preliminary report.

S√łndenaa K, Sen J, Heinle F, Fjetland L, Gudlaugsson E, Syversen U.

World J Surg. 2004 Sep;28(9):890-5.

PMID:
15593463
12.

Surgical experience with nonfunctioning neuroendocrine tumors of the pancreas.

Matthews BD, Heniford BT, Reardon PR, Brunicardi FC, Greene FL.

Am Surg. 2000 Dec;66(12):1116-22; discussion 1122-3.

PMID:
11149582
13.

The palliative benefit of aggressive surgical intervention for both hepatic and mesenteric metastases from neuroendocrine tumors.

Chambers AJ, Pasieka JL, Dixon E, Rorstad O.

Surgery. 2008 Oct;144(4):645-51; discussion 651-3. doi: 10.1016/j.surg.2008.06.008.

PMID:
18847650
14.

Resection of noncolorectal nonneuroendocrine liver metastases: a comparative analysis.

Reddy SK, Barbas AS, Marroquin CE, Morse MA, Kuo PC, Clary BM.

J Am Coll Surg. 2007 Mar;204(3):372-82.

PMID:
17324770
15.

Pancreaticoduodenectomy for islet cell tumors of the head of the pancreas: long-term survival analysis.

Sarmiento JM, Farnell MB, Que FG, Nagorney DM.

World J Surg. 2002 Oct;26(10):1267-71. Epub 2002 Sep 4.

PMID:
12205558
16.

Laparoscopic radiofrequency ablation of neuroendocrine liver metastases.

Berber E, Flesher N, Siperstein AE.

World J Surg. 2002 Aug;26(8):985-90. Epub 2002 May 21.

PMID:
12016479
17.

Metastatic endocrine tumors: medical treatment, surgical resection, or liver transplantation.

Dousset B, Saint-Marc O, Pitre J, Soubrane O, Houssin D, Chapuis Y.

World J Surg. 1996 Sep;20(7):908-14; discussion 914-5.

PMID:
8678970
18.

Surgical resection of hepatic and pulmonary metastases from colorectal carcinoma.

Shah SA, Haddad R, Al-Sukhni W, Kim RD, Greig PD, Grant DR, Taylor BR, Langer B, Gallinger S, Wei AC.

J Am Coll Surg. 2006 Mar;202(3):468-75. Epub 2006 Jan 18.

PMID:
16500252
19.

Liver transplantation for metastatic neuroendocrine tumors.

Lang H, Oldhafer KJ, Weimann A, Schlitt HJ, Scheumann GF, Flemming P, Ringe B, Pichlmayr R.

Ann Surg. 1997 Apr;225(4):347-54. Review.

20.

Resection of liver metastases from a noncolorectal primary: indications and results based on 147 monocentric patients.

Elias D, Cavalcanti de Albuquerque A, Eggenspieler P, Plaud B, Ducreux M, Spielmann M, Theodore C, Bonvalot S, Lasser P.

J Am Coll Surg. 1998 Nov;187(5):487-93.

PMID:
9809564

Supplemental Content

Support Center